Tuesday, November 5, 2019

Intra-Cellular Therapies EPS beats by $0.18

Intra-Cellular Therapies (NASDAQ:ITCI): Q3 GAAP EPS of -$0.63 beats by $0.18.
Cash, cash equivalents and investment securities of $255.4M
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.